Tin diiododeuteroporphyrin and therapeutic use thereof
AssigneeThe Rockefeller University
InventorsDarryl Rideout, Attallah Kappas, George S. Drummond
Life of this patent
Estimating the term…
Abstract
Use of the novel compound tin diiododeuteroporphyrin and compositions containing it to inhibit heme mebabolism in mammals, to control the rate of tryptophan metabolism in mammals, and to increase the rate at which heme and iron are excreted by mammals.
Claims5
Tin diiododeuteroporphyrin.
A pharmaceutical composition for parenteral administration comprising tin diiododeuteroporphyrin and pharmaceutically acceptable carrier.
A pharmaceutical composition in dosage unit form for parenteral administration comprising tin diiododeuteroporphyrin at a concentration of 0.5 .mu.mol/ml to 25 .mu.mol/ml in a pharmaceutically acceptable carrier.
A method of decreasing the rate of metabolism of heme in mammals in need of such treatment by administering to the mammal an amount of tin diiododeuteroporphyrin which is effective to decrease said rate.
Dependencies are inferred from the claim text.